1861 - 1870 of 7942 Results
Title
Year
- The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunction2022RESTRICTEDTitle: The path linking excessive daytime sleepiness and activity of daily living in Parkinson’s disease: the longitudinal mediation effect of autonomic dysfunctionJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4777End Page: 4784Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10072-022-06081-0Citation Count: 3
- A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity2022OPENTitle: A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversityJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abn0044Citation Count: 28
-
RESTRICTEDTitle: Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 5Start Page: 1567End Page: 1574Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-223223Citation Count: 6
- DARQ: Deep learning of quality control for stereotaxic registration of human brain MRI to the T1w MNI-ICBM 152 template2022OPENTitle: DARQ: Deep learning of quality control for stereotaxic registration of human brain MRI to the T1w MNI-ICBM 152 templateJournal Name: NeuroImagePublisher: Elsevier BVVol: 257Issue #:Start Page: 119266End Page: 119266Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuroimage.2022.119266Best OA location URL: https://doi.org/10.1016/j.neuroimage.2022.119266Citation Count: 14
-
OPENTitle: Effect of olfactory bulb pathology on olfactory function in normal agingJournal Name: Brain PathologyPublisher: WileyVol: 32Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/bpa.13075Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424999Citation Count: 21
-
OPENTitle: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease DementiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 4Start Page: 479End Page: 483Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13451Best OA location URL: https://doi.org/10.1002/mdc3.13451Citation Count: 16
- Pathway‐Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's Disease2022OPENTitle: Pathway‐Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1164End Page: 1174Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29030Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29030Citation Count: 8
- Recurrent Biallelic p.L347P PINK1 Variant in Polynesians with Parkinsonism and Isolated Dopa‐Responsive Dystonia2022OPENTitle: Recurrent Biallelic p.L347P PINK1 Variant in Polynesians with Parkinsonism and Isolated Dopa‐Responsive DystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 5Start Page: 696End Page: 697Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13467Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13467Citation Count: 4
- Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial2022OPENTitle: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJournal Name: eBioMedicinePublisher: Elsevier BVVol: 80Issue #:Start Page: 104021End Page: 104021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104021Best OA location URL: http://www.thelancet.com/article/S2352396422002055/pdfCitation Count: 36
-
RESTRICTEDTitle: DYT‐TUBB4A (DYT4 Dystonia): Clinical Anthology of 11 Cases and Systematized ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 5Start Page: 659End Page: 675Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13452Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13452Citation Count: 7